HLA-C and neoplasm: Alternatively, through this study, we revealed that many of thesetargeted inhibitors are also capable of upregulating tumor cell MHC expression andIFNg secretion, which may, consequently, enhance tumor immune surveillance andrecognition by cytolytic T-cells.